Biotech Peptides
$45.00- Price / mg
- $4.50
- Document access
- Public link
Free USPS Priority over $200; lower-order rate not stated
Research price index / 10 mgPT-141 (Bremelanotide) 10 mg
Fast comparison 01 02
PT-141 (Bremelanotide) 10 mg
price comparison.
Three public US 10 mg PT-141 research listings compared on exact nominal size, list price, availability language, public evidence route, shipping claim, and checked date.
Current answer. As of Jul 23, 2026, 2 confirmed in-stock listings run from $45.00 to $47.29, with a $46.14 median across the in-stock rows. All 3 seller pages remain visible below.
Start with the two lowest confirmed in-stock rows.
3/3 current price and availability signals rechecked July 28, 2026 at 4:47 PM UTC.Pepta Labs
$47.29- Price / mg
- $4.73
- Document access
- On request
Free US shipping claimed
A list-price starting point, not a product-quality, safety, or seller recommendation.
Melanocortin analoguesPT 141BremelanotideVyleesi
In-stock from$45.00
In-stock high$47.29
Spread5%
CheckedJul 23
Price and evidence decision lens
Three numbers before a source click.
List price, document access, and final landed cost answer different questions. This view keeps them separate instead of turning them into one seller score.
Biotech Peptides
Free USPS Priority over $200; lower-order rate not stated
Open vendor evidence profile →Biotech Peptides
COA, LC, and MS images. Access is public, but authenticity and custody are not established.
Inspect transparency record →Same lowest row
This difference compares list prices only. It does not assign value to a report or include shipping.
Calculate landed cost →How to read it: The Biotech Peptides row is both the lowest confirmed in-stock list price and the lowest row with a public document route. Document visibility is not product verification.
Filter PT-141 (Bremelanotide) vendors by stock, price, and public documents →Laboratory research category.Not an approved product for human use, medical treatment, or veterinary use.
3/3 rows shown
Commercial-link disclosure: we may earn a commission after a click. Placement does not change price rank. Seller testing claims are labeled, not treated as our own verification.
Current board2 of 3 in stockAvailable list range $45.00–$47.29
Rank rule. Price rank is availability-aware and stays fixed when you search or re-sort this view. Affiliate status never enters the calculation.
Compare two lowest in-stock rowsCustom comparisonChoose two rows for a landed-cost check.Select any two seller rows. The calculator carries over list price and nominal milligrams, then lets you add shipping and mandatory fees.
0 / 2 selected
Select 2 more rowsLatest source recheck3/3current price and availability signals confirmed
Checked July 28, 2026 at 4:47 PM UTC. Confirmed means the public source matched the published price and returned a reliable current availability signal. No row needs manual review. This does not verify vial contents or product quality.
Open source-check ledger| Price rank / supplier | 10 mg price | Price / mg | Public evidence | Shipping claim | Open listing |
|---|---|---|---|---|---|
01Biotech PeptidesPublic size-specific documentsIn stock | $45.00Source confirmed | $4.50 | COA, LC, and MS imagesAccess: Public link · Seller claim · Jul 23, 2026 | Free USPS Priority over $200; lower-order rate not stated | |
02Pepta LabsPrice updated Jul 21In stock | $47.29Source confirmed | $4.73 | COA on requestAccess: On request · Seller claim · Jul 23, 2026 | Free US shipping claimed | |
03Core PeptidesLower price; stock label absentStatus not stated | $43.00Source confirmed | $4.30 | COA tab shownAccess: Public link · Seller claim · Jul 23, 2026 | Free over $200; lower-order rate at checkout |
01$45.00
Biotech Peptides
Public size-specific documents · In stock- Per mg
- $4.50
- Evidence
- COA, LC, and MS imagesPublic link
- Shipping
- Free USPS Priority over $200; lower-order rate not stated
Source confirmedThe current public seller source returned the same exact-product price and a reliable availability signal. The dated base row remains a separate observation.
Audit record 02$47.29
Pepta Labs
Price updated Jul 21 · In stock- Per mg
- $4.73
- Evidence
- COA on requestOn request
- Shipping
- Free US shipping claimed
Source confirmedThe current public seller source returned the same exact-product price and a reliable availability signal. The dated base row remains a separate observation.
Audit record 03$43.00
Core Peptides
Lower price; stock label absent · Status not stated- Per mg
- $4.30
- Evidence
- COA tab shownPublic link
- Shipping
- Free over $200; lower-order rate at checkout
Source confirmedThe current public seller source returned the same exact-product price and a reliable availability signal. The dated base row remains a separate observation.
Audit record 1 In-stock headline prices exclude unavailable listings, coupons, and checkout-only discounts.
2 A seller COA or report is labeled as a claim unless Peptide Local commissioned the sample and controlled custody.
How we read a certificate of analysis →How to verify the seller and access route →Exact-listing document checkpoints
A COA is not one check.
Start with how the document can be reached, then match it to this exact PT-141 (Bremelanotide) 10 mg row. Access is useful evidence, but it does not prove authenticity, custody, vial contents, sterility, or suitability.
Pepta Labs
COA on requestThe exact 10 mg page was in stock and described third-party HPLC purity and ESI-MS identity testing with a batch certificate available by request.
- First action
- Request before relying
- First check
- Ask for the exact current-lot report, its date, analytical methods, and a laboratory verification route.
- Source checked
- Jul 23, 2026
Biotech Peptides
COA, LC, and MS imagesThe exact 10 mg page exposed seller-hosted COA, liquid-chromatography, and mass-spectrometry images. Peptide Local did not verify the represented lot or chain of custody.
- First action
- Inspect before relying
- First check
- Match the exact compound, nominal size, lot or batch identifier, report date, and named laboratory.
- Source checked
- Jul 23, 2026
Core Peptides
COA tab shownThe exact 10 mg page showed a price, ordering control, and certificate-of-analysis tab. A separate stock label was not captured, so it does not set the available low.
- First action
- Inspect before relying
- First check
- Match the exact compound, nominal size, lot or batch identifier, report date, and named laboratory.
- Source checked
- Jul 23, 2026
Use the same ten fields every time.
The free checker keeps compound identity, lot matching, dates, laboratory attribution, report verification, custody, purity, identity testing, instrument output, and quantity separate.
Provider matchups for this board
Compare sellers without losing the PT-141 (Bremelanotide) row.
These canonical matchups open directly on the PT-141 (Bremelanotide) 10 mg board. Price, stock, document access, source freshness, and shipping stay separate.
Pepta LabsvsBiotech Peptides
- Pepta Labs
- $47.29In stock
- Biotech Peptides
- $45.00In stock
Biotech Peptides is $2.29 lower before shipping.
- DocumentsOn request / Public link
- Source recheck16/16 / 12/12
Core PeptidesvsBiotech Peptides
- Core Peptides
- $43.00Status not stated
- Biotech Peptides
- $45.00In stock
Biotech Peptides is the only row marked in stock.
- DocumentsPublic link / Public link
- Source recheck16/16 / 12/12
Pepta LabsvsCore Peptides
- Pepta Labs
- $47.29In stock
- Core Peptides
- $43.00Status not stated
Pepta Labs is the only row marked in stock.
- DocumentsOn request / Public link
- Source recheck16/16 / 16/16
Pair selection prioritizes rows that are currently comparable, include the board low, or expose a meaningful document-access contrast. It is not a seller ranking.
Dated price history / 2026-07-21
Pepta Labs changed this exact 10 mg row.
The public list price moved from $42.99 in Peptide Local's 2026-07-17 snapshot to $47.29 after four matching source checks. That is a $4.30 increase, or 10.00%.
The listing was recorded as in stock at publication and displayed at price position 2 on the current exact-size board. Unavailable rows cannot set the current in-stock low. Price movement does not establish product identity, quality, safety, or market-wide inflation.
Open the complete PT-141 (Bremelanotide) price history →Open the full peptide price change record →Category context
Keep the category boundary visible.
Bremelanotide is the active ingredient in FDA-approved Vyleesi, but that prescription product has a specific 1.75 mg presentation, indication, label, and regulated supply chain. These 10 mg research listings are not approval-equivalent.
Read the current DailyMed drug label ↗Identity, evidence, and worldwide status
PT-141 (Bremelanotide) decision map.
Price, chemical identity, clinical evidence, approved-product status, and local supply are different questions. This map shows which source answers each one and leaves unresolved fields visible.
Evidence routes checked through Jul 23, 20263US price records
2confirmed in stock
1in-stock public document routes
42country verification guides
4country-specific status findings
US research-market identity with a separate FDA-approved medicine record
This record resolves seller-labelled 10 mg PT-141 research listings. VYLEESI is a separate FDA-approved bremelanotide prescription product with a 1.75 mg presentation, defined indication, label, and regulated supply chain. The research listings do not inherit that approval.
Read the current DailyMed drug labelNational Library of Medicine, DailyMed↗3 exact-size seller records
The price board can compare current list price, nominal size, availability, shipping language, and seller document access. It cannot establish identity, quantity, purity, sterility, legality, or fitness for use.
Inspect every price and source row2 currently confirmed in stock↓Run the exact intervention search
PT-141 (Bremelanotide) is outside Peptide Local's current 13-program trial-count snapshot. That means no local count is published here, not that the count is zero. Search the live registry, then inspect the intervention, status, population, and posted results for each record.
Search Bremelanotide on ClinicalTrials.govLive official registry route, not a cached result count↗42 countries across 5 regions
The global index joins this identity to official product and seller or supply routes in 22 content languages. Only 4 countries currently have a separate compound-specific status finding in this dataset.
Open the complete worldwide mapIdentity, product, seller, and supply checks stay separate↗Compound-specific country evidence4 current country findings with their boundaries
A country finding applies only to the cited identity, destination, source date, and stated scope. It does not authenticate a different product or seller.
Research listing separated from FDA-approved VYLEESI
VYLEESI is an FDA-approved bremelanotide prescription product under NDA 210557 with a 1.75 mg autoinjector presentation and product-specific label. The 10 mg PT-141 research listings tracked here are not VYLEESI and do not inherit its approval or regulated supply chain.
Named in a Health Canada unauthorized product seizure
Health Canada records PT-141 among unauthorized injectable peptide products seized in Calgary. That record does not authenticate every same-name listing and does not transfer the identity or approval of the US VYLEESI prescription product to a research vial.
Named in SAHPRA public guidance on unregistered peptide products
SAHPRA names PT-141 among peptide products unlawfully marketed in South Africa and states that products intended to treat, prevent, or alter bodily functions must be registered before sale. That guidance does not authenticate a specific online listing or seller.
Research listing separated from medicine authorization requirements in Italy
The 10 mg PT-141 research listings tracked here are not the US VYLEESI prescription product and do not inherit its FDA approval. AIFA states that a medicinal product must have marketing authorization from AIFA or the European Commission before it can be marketed in Italy. The linked Italian records must be searched for the exact product and presentation. They do not establish that a same-name online vial is authorized, available, lawful, or equivalent to VYLEESI.
What this page can tell you
The public commercial snapshot.
It can show the visible list price, normalized unit cost, availability label, delivery claim, document language, destination market, and date checked.
What it cannot tell you
What is actually in a vial.
A seller page or uploaded certificate does not replace independent sampling, chain-of-custody evidence, regulatory authorization, or professional judgment.
PT-141 (Bremelanotide) price comparison FAQ
Direct answers with the trade-offs attached.
Current exact-size answers for price, document access, shipping, and source checks. No seller is converted into a product-quality or safety recommendation.
What is the lowest current PT-141 (Bremelanotide) 10 mg price?
As of Jul 23, 2026, the lowest confirmed in-stock public list price in Peptide Local's exact-size US research-market sample is $45.00 from Biotech Peptides. Shipping, tax, coupons, subscriptions, bundles, and checkout-only fees are not included.
Which PT-141 (Bremelanotide) listings have public document access?
1 confirmed in-stock row link to a public seller document route: Biotech Peptides. The lowest of those rows is Biotech Peptides at $45.00. Public access does not authenticate a report, establish custody, or prove the contents of a supplied vial.
Does the lowest PT-141 (Bremelanotide) price include shipping?
No. The board compares public single-unit list prices for the same 10 mg nominal size. The current lowest row states: Free USPS Priority over $200; lower-order rate not stated. Use the landed-cost calculator before treating the list-price order as the final order cost.
What should I check before buying a seller-labelled PT-141 (Bremelanotide) research listing?
Confirm the exact identity and nominal size, current availability, landed cost, seller identity, destination-market rules, document route, lot or batch matching, analytical method, and source date. A seller-labelled research listing is not an approved medicine and public price or document access does not establish identity, purity, quantity, sterility, safety, legality, or fitness for human use.
How do I check a PT-141 (Bremelanotide) COA or laboratory report?
Start by matching the exact PT-141 (Bremelanotide) identity and 10 mg listing to a current lot or batch identifier. Then check analysis date, named laboratory, report verification route, sample custody, separate purity and identity methods, instrument output, and any measured quantity result. Peptide Local's free ten-field checker can organize those questions, but document completeness does not prove authenticity or the contents of a supplied vial.
Related peptide comparisons
Keep PT-141 (Bremelanotide) in the right row.
These pair guides compare research-market identity, exact board size, seller overlap, price footprint, and evidence access. They do not rank effects or recommend personal use.
Country, state & city context
Check the market route where you are.
These guides explain local verification and access routes. They do not relabel this US research-price board as local inventory or medical availability.